Skip to main content

Advertisement

Table 1 The expression levels of miRNAs related to synaptic proteins

From: Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease

Cohort 1 Cohort 2
  HC MCI AD HC FTD
Cohort size 14 26 56 24 27
Men/women 7/7 10/16 15/41 11/13 17/10
Age (years) 68.29 ± 8.99 72.0 ± 8.49 77.77 ± 6.69 67.03 ± 5.05 68.87 ± 7.48
GDS 2.07 ± 0.26 3.15 ± 0.37 4.64 ± 1.02 1 ± 0 3.76 ± 0.99
MMSE 29.21 ± 1.05 26.92 ± 2.22 16.05 ± 7.23 28.5 ± 1.69 25.5 ± 3.76
  1. All data are shown as mean ± SD
  2. HC cognitively healthy controls, MCI mild cognitive impairment, AD Alzheimer’s disease, FTD frontotemporal dementia, MMSE Mini-Mental State Examination, GDS Global Deterioration Scale